Drug action on adenylate kinase activity in cerebrospinal fluid of arteriosclerotic patients
- 1 December 1980
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 36 (12), 1409-1410
- https://doi.org/10.1007/bf01960129
Abstract
A manifest presence of adenylate kinase activity in cerebrospinal fluid was found in patients with cerebral arteriosclerosis. This activity was significantly higher during treatment with co-dergocrine (Hydergin®) compared with the two periods before and after treatment.Keywords
This publication has 7 references indexed in Scilit:
- Adenylate kinase activity in cerebrospinal fluid of schizophrenic and certain other psychiatric symptomatologiesActa Psychiatrica Scandinavica, 1979
- Cerebrospinal Fluid Content of Adenylate Kinase, Lactate and Glutathione in Patients with MeningitisScandinavian Journal of Infectious Diseases, 1979
- Adenylate Kinase Activity and Glutathione Concentration of Cerebrospinal Fluid in Different Neurological DisordersEuropean Neurology, 1979
- The influence of adrenergic effectors on the cationic pump of brain cell membrane.1975
- Cerebral Metabolic Changes During Treatment of Subacute Cerebral Infarction by Alpha and Beta Adrenergic Blockade With Phenoxybenzamine and PropranololStroke, 1974
- The effects of a soluble factor and of catecholamines on the activity of adenosine triphosphatase in subcellular fractions of rat brainBiochemical Pharmacology, 1972
- Accumulation of cyclic adenosine monophosphate in incubated slices of brain tissue. 1. Structure-activity relation of agonists and antagonists of biogenic amines and of tricyclic tranquilizers and antidepressantsJournal of Medicinal Chemistry, 1972